Coloplast Valuation
| COLO-B Stock | DKK 730.60 1.60 0.22% |
At this time, the firm appears to be overvalued. Coloplast AS shows a prevailing Real Value of kr679.46 per share. The current price of the firm is kr730.6. Our model approximates the value of Coloplast AS from analyzing the firm fundamentals such as Profit Margin of 0.20 %, current valuation of 203.46 B, and Return On Equity of 0.75 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Coloplast's price fluctuation is very steady at this time. Calculation of the real value of Coloplast AS is based on 3 months time horizon. Increasing Coloplast's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Coloplast is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Coloplast Stock. However, Coloplast's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 730.6 | Real 679.46 | Hype 730.6 | Naive 723.22 |
The real value of Coloplast Stock, also known as its intrinsic value, is the underlying worth of Coloplast AS Company, which is reflected in its stock price. It is based on Coloplast's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Coloplast's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Coloplast AS helps investors to forecast how Coloplast stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Coloplast more accurately as focusing exclusively on Coloplast's fundamentals will not take into account other important factors: Coloplast Total Value Analysis
Coloplast AS is currently expected to have takeover price of 203.46 B with market capitalization of 175.43 B, debt of 16.36 B, and cash on hands of 620 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Coloplast fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
203.46 B | 175.43 B | 16.36 B | 620 M |
Coloplast Investor Information
About 35.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 21.76. Coloplast AS last dividend was issued on the 2nd of December 2022. The entity had 5:1 split on the 19th of December 2012. Based on the key indicators related to Coloplast's liquidity, profitability, solvency, and operating efficiency, Coloplast AS is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Coloplast Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Coloplast has an asset utilization ratio of 64.59 percent. This suggests that the Company is making kr0.65 for each dollar of assets. An increasing asset utilization means that Coloplast AS is more efficient with each dollar of assets it utilizes for everyday operations.Coloplast Ownership Allocation
Coloplast holds a total of 194.31 Million outstanding shares. Coloplast AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Coloplast Profitability Analysis
The company reported the revenue of 22.58 B. Net Income was 4.71 B with profit before overhead, payroll, taxes, and interest of 15.53 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Coloplast's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Coloplast and how it compares across the competition.
About Coloplast Valuation
The stock valuation mechanism determines Coloplast's current worth on a weekly basis. Our valuation model uses a comparative analysis of Coloplast. We calculate exposure to Coloplast's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Coloplast's related companies.Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast operates under Healthcare Products classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 12000 people.
8 Steps to conduct Coloplast's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Coloplast's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Coloplast's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Coloplast's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Coloplast's revenue streams: Identify Coloplast's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Coloplast's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Coloplast's growth potential: Evaluate Coloplast's management, business model, and growth potential.
- Determine Coloplast's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Coloplast's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Coloplast Stock analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |